Robert Barrie

1 week ago | medicaldevice-network.com | Robert Barrie

Surgeons on England’s National Health Service (NHS) will be able to use state-of-the-art robotic systems that will improve the care of patients undergoing a range of procedures. A total of 11 systems are set to be used across the health service after positive recommendation by the National Institute for Health and Care Excellence (NICE). Five robotic systems have been greenlit for soft tissue procedures such as hernia repair, removal of tumours, and gall bladder removal.

1 week ago | pharmaceutical-technology.com | Robert Barrie

Skip to site menuSkip to page content Pharmaceutical companies are demanding changes in European regulation as looming tariffs implemented by US President Donald Trump “threaten” billions of planned pharma investments on the continent.

1 week ago | medicaldevice-network.com | Robert Barrie

Abbott has posted strong revenue for its diabetes devices in Q1, despite overall sales for the company narrowly missing Wall Street expectations. The medtech giant posted an increase in year-over-year overall revenue of 4%, giving total takings of $10.36bn. After reporting a positive adjusted first-quarter profit of $1.09 per share, shares in the company rose 1% at market open today (16 April). Share prices rose further into the mid-morning. Abbott has a market cap $218.9bn.

1 week ago | pharmaceutical-technology.com | Robert Barrie

Skip to site menuSkip to page content Member states of the World Health Organization (WHO) have reached an agreement on how to tackle future pandemics courtesy of a new treaty that will facilitate international collaboration and shared response efforts. The draft agreement, which will be put forth at an upcoming World Health Assembly in May, comes after three years of negotiations between governments.

1 week ago | pharmaceutical-technology.com | Robert Barrie

Skip to site menuSkip to page content “I am taking compounded semaglutide that I ordered online, but I don’t know how long I will have access to it.”That was what one anonymous patient told Pharmaceutical Technology on an online compounded semaglutide forum on Reddit with over 10,000 members.